Precision Optics Corporation, Inc. (POCI) P/E Ratio History
Deep ValueTrading at -6.2x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 1994–2023
Loading P/E history...
P/E Ratio Analysis
As of June 24, 2026, Precision Optics Corporation, Inc. (POCI) trades at a price-to-earnings ratio of -6.2x, with a stock price of $5.26 and trailing twelve-month earnings per share of $-0.63.
The current P/E is 114% below its 5-year average of 45.0x. Over the past five years, POCI's P/E has ranged from a low of 7.0x to a high of 131.3x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.0x, POCI trades at a 128% discount to its sector peers. The sector includes 233 companies with P/E ratios ranging from 0.0x to 196.5x.
Relative to the broader market, POCI trades at a notable discount to the S&P 500 median P/E of 24.6x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our POCI DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
POCI Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
POCI P/E vs Peers
Surgical and interventional devices peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $12B | 333.1 | 72.99 | +225%Best | |
| $59B | 2237.6 | - | +105% | |
| $1B | 36.7 | - | +124% | |
| $28B | 32.5Lowest | 2.65 | +10% | |
| $143B | 51.2 | 2.35Best | +23% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
POCI Historical P/E Data (1994–2023)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2023 Q3 | Mar 31 2023 | $6.79 | $0.06 | 116.1x | +158% |
| FY2023 Q2 | Dec 31 2022 | $5.57 | $0.11 | 51.2x | +14% |
| FY2021 Q4 | Jun 30 2021 | $5.04 | $0.04 | 131.3x | +192% |
| FY2021 Q3 | Mar 31 2021 | $4.98 | $0.05 | 103.5x | +130% |
| FY2012 Q4 | Jun 30 2012 | $13.50 | $1.28 | 10.5x | -77% |
| FY2012 Q3 | Mar 31 2012 | $9.00 | $1.29 | 7.0x | -84% |
| FY2012 Q2 | Dec 31 2011 | $12.60 | $1.55 | 8.1x | -82% |
| FY2012 Q1 | Sep 30 2011 | $11.25 | $1.39 | 8.1x | -82% |
| FY1997 Q3 | Mar 31 1997 | $506.25 | $4.87 | 104.0x | +131% |
| FY1997 Q2 | - | $506.25 | $54.45 | 9.3x | -79% |
| FY1997 Q1 | Sep 30 1996 | $562.50 | $36.00 | 15.6x | -65% |
| FY1996 Q4 | Jun 30 1996 | $843.75 | $31.50 | 26.8x | -40% |
| FY1996 Q3 | Mar 31 1996 | $464.06 | $33.30 | 13.9x | -69% |
| FY1996 Q2 | Dec 31 1995 | $675.00 | $24.30 | 27.8x | -38% |
| FY1996 Q1 | Sep 30 1995 | $759.38 | $47.25 | 16.1x | -64% |
| FY1995 Q4 | Jun 30 1995 | $548.44 | $29.25 | 18.8x | -58% |
| FY1995 Q3 | Mar 31 1995 | $562.50 | $27.00 | 20.8x | -54% |
| FY1995 Q2 | Dec 31 1994 | $562.50 | $18.00 | 31.3x | -31% |
| FY1995 Q1 | Sep 30 1994 | $675.00 | $7.50 | 90.0x | +100% |
| FY1994 Q4 | - | $675.00 | $7.50 | 90.0x | +100% |
Average P/E for displayed period: 45.0x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
32+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
POCI — Frequently Asked Questions
Quick answers to the most common questions about buying POCI stock.
What is POCI's P/E ratio?
Precision Optics Corporation, Inc. (POCI) trailing twelve-month P/E ratio is -6.2x, based on TTM diluted EPS of $-0.63. The 5-year average P/E is 45.0x and the historical range spans 7.0x to 131.3x.
Is POCI stock overvalued or undervalued?
POCI trades at -6.2x P/E, below its 5-year average of 45.0x. At the 0th percentile of its historical range (7.0x–131.3x), the stock is priced at a discount to its own history.
Is POCI stock expensive?
No, POCI is not expensive on a historical basis. The current P/E of -6.2x is below the 5-year average of 45.0x and sits at the 0th percentile of its valuation range.
What is POCI's historical P/E range?
Over the past 5 years, POCI's P/E ratio has ranged from 7.0x to 131.3x, with a median of 26.8x and an average of 45.0x. The current P/E of -6.2x places the stock at the 0th percentile of this range. Full historical data spans 1994–2023.
How does POCI's P/E compare to the S&P 500?
POCI trades at -6.2x P/E versus the S&P 500 median of 24.6x. The 125% discount to the market suggests lower growth expectations or perceived higher risk.
How does POCI's valuation compare to Healthcare peers?
Precision Optics Corporation, Inc. P/E of -6.2x compares to the Healthcare sector median of 22.0x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is POCI's PEG ratio?
POCI PEG ratio is N/A, based on a P/E of -6.2x and EPS growth of -73.5%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is POCI's earnings yield?
POCI earnings yield is N/A, the inverse of its -6.2x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.